.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Nama is stocked at 110 licensed dispensaries across New York, New Jersey, and Minnesota, 85 of them in New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and The Bronx. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
Nama operated as a single-category brand in August 2026, with Edible accounting for 100.0% of sales and an average price of $15.73. Within Edible, sales grew 141.6% year over year while declining 10.8% month over month, and average price fell 8.5% YoY alongside the full-category focus persisting at 100.0% share. The brand ranked 26 in Edible in New York, indicating expansion versus August 2025 but a step down versus July 2026 if rank slid in tandem with the 10.8% MoM revenue dip; together these shifts imply an aggressive volume-driven posture within Edible that is still sensitive to month-level demand fluctuations.
The combination of a 141.6% YoY sales gain and an 8.5% YoY price decrease suggests Nama prioritized unit growth over per-unit margin, consistent with a single-category strategy that keeps Edible at 100.0% of mix while accepting a 10.8% MoM revenue contraction. Holding rank 26 in New York Edible while pricing below last year points to a positioning anchored in accessible price tiers and broad appeal rather than premium segmentation; the implication is that sustaining share gains will depend on maintaining price elasticity benefits and repeat rates within Edible rather than diversifying into adjacent categories.
Competitive Landscape
Nama ranks #26 in NY Edible in August 2026, improving 11 places from #37 year over year and 5 places from #31 in May 2026, marking a new peak rank of #26 also set in August 2026; meanwhile, Camino moved from #2 to #1 with 10.5% sales growth year over year while Off Hours slipped from #1 to #2 with a 24.8% sales decline, indicating that Nama’s upward rank mobility is occurring amid a reshuffle at the top and implies momentum toward mid-tier relevance if the August 2026 peak can be sustained into the next quarter.
Notable Products
The steepest movement in August 2026 came from Euphoria - Sour Berry RSO Gummies 2-Pack (100mg), which fell 62.6% MoM while holding the number 7 rank, signaling acute volatility within the RSO sub-line. At the top, Euphoria - Fresh Strawberry RSO Gummies 2-Pack (100mg) slid 29.0% MoM yet remained number 1, and Euphoria - Sour Diesel x Pear Live Resin Gummies 2-Pack (100mg) dropped 16.5% MoM at number 2, pointing to broad pressure on leading SKUs. Meanwhile, CBD/CBN/THC 1:1:1 Sleep Plus Midnight Berries Gummies 20-Pack (100mg CBN, 100mg CBD, 100mg THC) was relatively stable at -1.3% MoM in the number 5 spot with $13,245 in sales, as two Live Resin SKUs in the top ten posted MoM gains of 19.1% and 20.7%, indicating selective demand for terpene-forward formulations. With all top-ten items in Edible and multiple RSO entries losing share while Live Resin pockets grow, the product mix implies a pivot opportunity toward Live Resin profiles and sleep-oriented formats to offset RSO volatility.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
